Author:
Taïeb Julien,Sayah Lina,Heinrich Kathrin,Kunzmann Volker,Boileve Alice,Cirkel Geert,Lonardi Sara,Chibaudel Benoist,Turpin Anthony,Beller Tamar,Hautefeuille Vincent,Vivaldi Caterina,Mazard Thibault,Bauguion Lucile,Niger Monica,Prager Gerald W.,Coutzac Clelia,Benedikt Westphalen C.,Auclin Edouard,Pilla Lorenzo
Reference20 articles.
1. More deaths from pancreatic cancer than breast cancer in the EU by 2017;Ferlay;Acta Oncol,2016
2. How I treat pancreatic cancer;Taieb;ESMO Open,2020
3. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ducreux;Ann Oncol,2015
4. NAPOLI-1 Study Group. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial;Wang-Gillam;Lancet,2016
5. Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial;Oettle;J Clin Oncol,2014
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献